Suspected VITT blood clotting case after Johnson & Johnson COVID-19 vaccination

University of Utah Health announces a suspected case of vaccine-induced thrombotic thrombocytopenia (VITT), also called thrombosis and thrombocytopenia syndrome (TTS), after receiving the Johnson & Johnson COVID-19 vaccine. Confirmation of the diagnosis by the U.S. Centers for Disease Control and Prevention (CDC) is pending.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.